P110025S007

None

FDA Premarket Approval P110025 S007

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP110025S007
Classification NameNone
Applicant
PMAP110025
SupplementS007

Supplemental Filings

Supplement NumberDateSupplement Type
P110025Original Filing
S023 2018-10-26 Normal 180 Day Track No User Fee
S022 2018-10-09 30-day Notice
S021 2017-10-11 Real-time Process
S020 2017-08-03 30-day Notice
S019 2017-05-24 30-day Notice
S018 2016-12-07 Real-time Process
S017 2016-09-07 Normal 180 Day Track No User Fee
S016 2016-07-11 135 Review Track For 30-day Notice
S015 2016-02-16 30-day Notice
S014 2016-01-27 30-day Notice
S013 2016-01-27 135 Review Track For 30-day Notice
S012 2015-10-07 30-day Notice
S011 2014-10-16 Real-time Process
S010 2013-07-19 Special (immediate Track)
S009
S008 2012-11-30 30-day Notice
S007
S006 2012-02-29 30-day Notice
S005 2012-02-02 30-day Notice
S004 2012-02-02 30-day Notice
S003 2012-02-02 30-day Notice
S002 2012-01-31 135 Review Track For 30-day Notice
S001 2012-01-31 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.